QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 maximus-secures-31m-contract-to-provide-premium-billing-and-digital-services-for-massachusetts-health-connector

Latest contract expands the Company's state health insurance exchange market offerings to include premium billing servicesM...

 maximus-awarded-pennsylvanias-department-of-human-services-62m-contract-to-continue-administration-of-pennsylvania-enrollment-assistance-program

Renewed contract includes a digitally enhanced customer experience for the Children's Health Insurance Program recipientsMa...

 maximus-approves-400m-stock-buyback-to-boost-shareholder-value

Maximus (NYSE:MMS), a leading employer and provider of government services, announced today that its Board of Directors has aut...

 maximus-secures-77m-us-air-force-contract-to-expand-cybersecurity-and-cloud-services-for-dod

New contract expands cybersecurity portfolio within Department of Defense to support operational readiness and continued innova...

 pe-ratio-insights-for-maximus
P/E Ratio Insights for Maximus
07/03/2025 14:00:44

 maximus-raises-fy2025-adj-eps-guidance-from-590-620-to-630-660-vs-610-est-raises-fy2025-sales-guidance-from-520b-535b-to-525b-540b-vs-530b-est

Maximus (NYSE:MMS) raises FY2025 Adj EPS guidance from $5.90-$6.20 to $6.30-$6.60 vs $6.10 analyst estimate. Raises FY2025 sale...

 maximus-q2-adj-eps-201-beats-138-estimate-sales-136b-beat-129b-estimate

Maximus (NYSE:MMS) reported quarterly earnings of $2.01 per share which beat the analyst consensus estimate of $1.38 by 45.65 p...

 maximus-q1-adj-161-beats-106-estimate-sales-140b-beat-129b-estimate

Maximus (NYSE:MMS) reported quarterly adjusted earnings of $1.61 per share which beat the analyst consensus estimate of $1.06 b...

 raymond-james-upgrades-maximus-to-outperform-announces-90-price-target

Raymond James analyst Brian Gesuale upgrades Maximus (NYSE:MMS) from Market Perform to Outperform and announces $90 price ta...

 maximus-secures-medicare-contract-through-2031-shares-gain-momentum

Maximus announces CMS has canceled the early re-procurement of its Medicare contract, allowing the company to continue its curr...

 reported-earlier-maximus-retains-key-cms-contract-securing-contact-center-operations-through-2031

Maximus (NYSE:MMS) is pleased to announce that the U.S. Department of Health and Human Services, Centers for Medicare & Med...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION